The Case for Stamp Duty Cuts

The Case for Stamp Duty Cuts

However, in recent years, this document has been the subject of numerous debates and challenges, undergoing several revisions to reflect the evolving infrastructure landscape. One such critical issue which impacts the entire business model of PPPs is the application of stamp duty on the agreement. This article aims to analyse the stamp duty obligations applicable…

Read More
Making a Case for Moratorium on Deep Sea Mining Activities – Jindal Forum for International and Economic Laws

Making a Case for Moratorium on Deep Sea Mining Activities – Jindal Forum for International and Economic Laws

Deep-sea Mining (DSM) represents a pivotal intersection of resource extraction, environmental policy, and international law, particularly amid the ongoing climate crisis. As terrestrial mineral resources diminish, the deep seabed has attracted increasing interest for its untapped deposits of valuable minerals essential for renewable energy technologies, such as lithium and cobalt, intensifying global competition for these…

Read More
531055 750x450397355 cheque book.webp

S.138 NI Act | Cheque Dishonour Case Not Sustainable For Cash Debt Above Rs 20,000 Without Valid Explanation : Kerala High Court

The Kerala High Court recently passed a judgment declaring that debt created by a cash transaction above Rupees Twenty Thousand in violation of the Income Tax (IT) Act, 1961 cannot be considered as a legally enforceable debt unless there is a valid explanation for the same. Justice P.V. Kunhikrishnan clarified that even so, a person…

Read More
Trilegal, CAM, White & Case inject life into Anthem Biosciences’ Rs. 3,395 cr IPO, ETLegalWorld

Trilegal, CAM, White & Case inject life into Anthem Biosciences’ Rs. 3,395 cr IPO, ETLegalWorld

The stock ticker displaying Anthem Biosciences Ltd.’s successful IPO launch with a significant price surge. Confetti rains down as traders celebrate on the bustling exchange floor. Trilegal is guiding Bengaluru-headquartered drugmaker Anthem Biosciences, its promoters and other selling shareholders on the drugmaker’s initial public offering comprising an offer of sale of equity shares worth INR…

Read More